We attended ASCO 2019. ASCO is the American Society of Clinical Oncology. ASCO hosts, next to many other activities around oncology, an annual meeting.
This meeting provides clinical updates and educational sessions for oncologists, nurses, researchers and everybody interested in oncology from around the world. The 2019 meeting hosted more than 40’000 participants, an increase of ca. 30% over the last 7 years. The growth of participants indicates the level of innovation and investments which flow into the sector. These aspects stayed the same compared to previous years. However, a lot of other things have changed in 2019.
We attended the ASCO 2023 annual meeting in Chicago. After the rise of immuno-oncology, COVID-19 challenged clinical trial execution and muted patient numbers. In the last years we saw many setbacks of once promising immuno-oncology combinations trials.
What mattered this month in healthcare? Q1 reporting came to a close, and FTC action put pressure on the biopharma space and... Find out more in our monthly healthcare newsletter.
With M&A picking up, are we at a turning point for biotech? Check out our latest Kieger AG Chart of the Month Video.